NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Piramal Enterprises Limited (NSE: PEL)

 
PEL Technical Analysis
1.5
As on 26th Apr 2024 PEL SHARE Price closed @ 925.75 and we RECOMMEND Sell for LONG-TERM with Stoploss of 934.99 & Buy for SHORT-TERM with Stoploss of 875.96 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PELSHARE Price

Open 907.95 Change Price %
High 934.95 1 Day 17.80 1.96
Low 907.95 1 Week 90.60 10.85
Close 925.75 1 Month 67.50 7.86
Volume 3174677 1 Year 208.70 29.11
52 Week High 2354.25 | 52 Week Low 634.65
 
PEL CURRENT MONTH FUTURE
Close 931.45
Contracts Traded 4929750
Open Intrest 11442750
Change In O.I -3.53 %
Lot Size 750
PEL CURRENT MONTH OPTION
Most Active Call 1000.00
Most Active put 840.00
Highest O.I Buildup Call 1000.00
Highest O.I Buildup Put 800.00
Expiry Date 2024-05-30
PEL ALL MONTHS OPTIONS
For All PEL Options Click Here
 
NSE INDIA Most Active Stocks
IDEA 14.00 0.72%
YESBANK 26.15 0.77%
IRFC 158.05 5.19%
GMRINFRA 90.75 6.58%
HUDCO 228.10 12.34%
MAHABANK 67.65 3.68%
SAIL 168.55 2.18%
NHPC 92.55 1.65%
TATASTEEL 165.80 -1.13%
IDFCFIRSTB 84.80 1.68%
 
NSE INDIA Top Gainers Stocks
ROSSELLIND 468.35 20.00%
MGEL 23.25 19.85%
KIRLOSIND 5232.65 12.84%
HUDCO 228.10 12.34%
DPABHUSHAN 1133.45 10.42%
KECL 130.60 10.30%
EXCEL 0.55 10.00%
ACL 98.15 9.79%
ACL 98.15 9.79%
ACL 98.15 9.79%
 
NSE INDIA Top Losers Stocks
LTTS 4778.10 -7.81%
BAJFINANCE 6731.20 -7.73%
DBSTOCKBRO 50.90 -5.91%
COMPUSOFT 33.95 -5.56%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
 
 
PEL
Daily Charts
PEL
Intraday Charts
Whats New @
Bazaartrend
PEL
Free Analysis
 
PEL Important Levels Intraday
RESISTANCE977.78
RESISTANCE961.09
RESISTANCE950.78
RESISTANCE940.47
SUPPORT911.04
SUPPORT900.72
SUPPORT890.41
SUPPORT873.72
 
PEL Target April 2024
4th UP Target1180.96
3rd UP Target1102.29
2nd UP Target1053.66
1st UP Target1005.03
1st DOWN Target866.27
2nd DOWN Target817.64
3rd DOWN Target769.01
4th DOWN Target690.34
 
PEL Weekly Target
4th UP Target955.78
3rd UP Target917.09
2nd UP Target893.18
1st UP Target869.27
1st DOWN Target801.03
2nd DOWN Target777.12
3rd DOWN Target753.21
4th DOWN Target714.52
 
PEL Target2024
4th UP Target1913.21
3rd UP Target1598.34
2nd UP Target1403.71
1st UP Target1209.08
1st DOWN Target653.72
2nd DOWN Target459.09
3rd DOWN Target264.46
4th DOWN Target-50.41
 
 
PEL Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is 28.60 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 1203.28
10 Day Avg Volume Traded 1.03 % More then 10 Day Average Volume
 
PEL Other Details
Segment EQ
Market Capital 642499936256.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
PEL Address
PEL
 
PEL Latest News
 
Your Comments and Response on Piramal Enterprises Limited
 
PEL Business Profile
Piramal Enterprises Limited operates in financial services and pharmaceuticals businesses in India, North America, Europe, Japan, and internationally. It operates through Pharmaceuticals Manufacturing and Services, and Financial Services segments. The company provides financing to real estate developers, as well as corporate clients in non-real estate sectors. It also offers housing loans to individual customers; builds a retail lending platform; and engages in the investment activities. In addition, the company offers contract development and manufacturing solutions across the drug life cycle, including drug discovery, production, and manufacturing of active pharmaceutical ingredients and formulations; and inhalation and injectable anaesthesia, injectable pain, antibiotics, and other medications, as well as intrathecal spasticity management drugs. Further, it provides over-the-counter products for analgesics, skin care, vitamins and supplements, kids' wellness, digestives, women's health, and hygiene and protection primarily under the Saridon, Lacto Calamine, I-Pill, Supradyn, Polycrol, and Tetmosol brands. The company was formerly known as Piramal Healthcare Limited and changed its name to Piramal Enterprises Limited in July 2012. Piramal Enterprises Limited was incorporated in 1947 and is based in Mumbai, India. Address: Piramal Ananta, Mumbai, India, 400070
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service